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Parathyroid hormone (PTH) related peptide (PTHrP) 
is thought to influence the proliferation and differ-
entiation of the epidermis and hair follicle. As a 
means of elucidating the biologic function of PTHrP 
on the hair follicle, a PTHrP analog PTH (7-34), 
which is a PTH/PTHrP receptor antagonist, was 
given intraperitoneally twice daily to C57 BLl6 mice 
at different stages of the hair cycle. PTH (7-34) 
induced 99 ± 4.5% (mean ± SEM) of resting telogen 
hair follicles into a proliferative (anagen) state, 
whereas 100% of the hair follicles in the control group 
remained in telogen. To determine whether this pep-
tide influenced the progression of the hair follicles 
from anagen to catagen (hair follicle maturation and 
regression), groups of mice that were either sponta-
neously in or induced to anagen received either PTH 
P arathyroid hormo ne (PTH)-re lated peptide (PTHrP) is 3 141-3mino acid protein that shares 70% homology with PTH in its first 13 amino acids but dive rges completely in its primary struc ture thereafter (Broadus et ai, 1988; T hiede e/ ai, 1988; Orloff e/ ai, 1994; M artin 
et ai, 1991). Studi es using synthetic PTH and PT HrP amino-
te rminal fi'agm ents have demonstrated that these peptides bind to 
the PT H receptor and cause bio logic effects o n calcium and 
phosphorus m etabo lism . A PTH/ PTHrP receptor has been cloned, 
and it has been demonstrated that PTH/PTHrP ml~As are widely 
expressed in m any ti ssues unre la ted to calcium m e tabolism, includ-
ing the skin Uuppne r et ai, 1991; Ure na et ai, 1993) . PTHrP is 
similarl y expressed in severa l normal and neoplastic tissues, includ-
ing skin and hair follicl es (Me rendino e/ ai, 1986; H ayman e/ ai, 
1989; Atillasoy, 1991). Although the ph ys io log ic role ofPTHrP in 
the skin is no t well understood , mounting evidence suggests th at 
thi s p eptide plays an impo rtant role in e pidermal proliferation and 
differentiation 1.2 (Hende rson et ai, 1992; Kaiser ct ai , 1992) . Th e 
PTH/ PTHrP receptor agonist PTH (1-34) w as fOllnd to inhibit 
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(7-34) or placebo. Morphometric analysis of the hair 
follicles from the middle back region of the sponta~ 
neous anagen mice that received PTH (7-34) revealed 
that 19 ± 4% (mean ± SEM) of the follicles were in. 
anagen VI, whereas none (0%) were in anagen in the 
control group. Similarly, in induced anagen mice 
treated with PTH (7-34),22.3 ± 1.4 (mean ± SEM) o f 
the follicles were in anagen VI compared to only 
1.3 ± 0.7% in the control mice. Together these obser~ 
vations suggest that PTHrP is a hair follicle morpho~ 
gen that may be a major factor responsible for control~ 
ling the hair cycle. These studies provide a new insight 
for development ofPTHrP analogs for a wide variety o f 
disorders related to disturbances of hair cycling. Key 
lVords: paratllJIl'oid homlOlle rela.ted peptide/mice/hail' cycle/ 
a.llagell. ] I,,,,est Del,,"atol 108:928-932, 1997 
epiderma l proliferation in cultured human keratinocytes (HoUck el 
al. 1994), and ill IJilJO in SKH-1 hairless mice (Holi ck el ai, 1994). 
Evide nce that this e ffect was m ediated t1u'o ugh the PT H / PTHrP 
recepto r was provided by studies in which the addition of the 
PTH/ PTHrP receptor antagonist, PTH (7-34) reversed the PTH. 
(1-34)-induced anti-prolife rative effect on cultured ke ratinocytes 1 
(HoUck el ai, 1994). III vivo PTH (7-34) stimul ated , in a dose_ 
dependent fashion, [OH]thymidine incorporation into the e pider_ 
mis. Furthermore , PTH (7-34) increased the tota f-number of visible 
hair shafts and hair length by 146'X, and 80%, respectively (HoUck 
e/ ai, 1994) . To further investigate the biol ogic function of PTHrP 
as a possible regulator of hair growth, we investigated the effect of 
its antagoni st PT H (7-34) on the cyclic growth and regression o f 
hair follicles in mice with normal hair growth using the C57 BL/6 
m o use m ode l for hair research (Paus el ai, 1990, 19943, 1994b, 
1994c). 
MATElUALS AND METHODS 
C57 BL/G micc were purchased fro m Charles River Breeding Laboratories 
(W ilmington. MA) and fed a standard mouse chow diet ad Iibillllll . (Nles. l s 
TyrJ4J parathyroid hormone (7-34)-amide [PT H (7-34)J was purchased 
from Bachem California (Torrance. CAl. Two groups of six to seven 
telogen 24-d-old C57 BLiG mice were givcn either 1 p..g of PTH (7-34) in 
0. 1 1111 of distill ed water or 0. 1 ml of di stilled water twice daily interperi_ 
toneally for 14 d. The skin color for the mice in each group was evaluated 
on day 12. 13 . and 14 of trea tment as previously described (Paus el ai, 1990. 
2 Milstone L, Fairley J, Insogna K, Stewart A, Reuveni H: Para thyroid 
hOn1lOne-like peptides increase intracellular calcium and differentiation of 
kcratinocytes . J Cell Bioi 107:73A. 1988 (abstr) . 
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1994a, 1994c). On da)' 14 of treatment, the mice were sacrificed for 
histo logic and histomorphometric studies. T he mice were sacrificed on day 
14, and the whole back skin was harvested. Defined regions (neck, middle, 
and tajl area of the back) were obtained fo llowing a standardized protocol 
(Paus el nl, '1990. 1994a, 1994c). After histologic processing (fixation, 
pa[all'w embedding, Gcimsa staining), the morphologic analysis and pho-
togra phy of the longitudinal sec tions of full-thi ckness skin were performed 
at 100 and 40(1 X magnification. For each of the test m'ld control mice. at 
least 50 microscopic fie lds (10 X) were assessed per region of the back by 
morphometry. The data were pooled, and the means ± SEM and levels of 
signifi.cance were calculated using Mann-Whi tney U-tests. The middle back 
region of all experiments was selected for tlli s representation because it was 
the area with the most substantial changes. 
To evaluate the effect of PTH (7- 34) on inhibiting the progression of 
anagen into caragen, two groups contairung seven 28-d-old anagen mice 
were g iven either I I-'g of PTH (7- 34) in 0.11111 of disti lled water or 0. 1 ml 
of distilled water twice daily interperitoneally for 9 d. Analysis of skin color. 
skin histology. and histomorphometry were conducted as described above. 
To determine whether PTH (7- 34) could inhibit anagen-induccd matu-
ration of the hair fo llicle. tlll'ee groups of between four to six 6- to 8-wk-old 
telogen mice were depilated with a wax rosin. Starting on day 9 postdepi-
lation , when all mice had reached anagen, the mice were given either 1 I-'g 
PTH (7- 34) or vehicle twice daily intcrperi tonca lly fo r 10 d. The skin color. 
skin histology. 'll1d skin hist0l110rphol11ctry were evaluated as described 
above. Serlln1 ca lciulll 111easurelnellts 'were perfornlcd by OUT clinica l 
laboratory using an automated system. 
RESULTS 
Acceleration of Anagen by PTH (7-34) in 24-d-old Mice 
That: Were in Telogen We reasoned that ifPTHrP is a factor 
tbat regulates hair growth , then a PTH / PTHrP receptor antagonist 
[PTH (7-3 4)] could block the inhibitol'y activity of endogenous 
PTHrP on th e hai r cycle. T his would result in stimulation of the 
hair fo llicle from its telogen resting sta te into the proliferative 
anage n state, causing a prolongation of the duration of hair growth . 
We u sed the C5 7 BL/6 mouse, which ha s a highly synchronized 
hair cycle that can be easily evaluated because the hair follicle is the 
only location for melanin production , and melanin is only produced 
during active hair growth (Fig lA) (Straile e/ ai, 1961; Paus e/ ai, 
1990, 1994a, 1994c). T hus , skin color re liably indicated the 
different stages of the hair cycle. 
We studied infantile 24-d-old C57BL/6 mice to determine 
wheth er the impending spontaneous initiation of new hair growth 
(anagen wave) could be further accelerated by PTH (7-34) . There 
was a marked increase in th e amount of pigmentation on the 
infantile mice receiving PTH (7-34) , indicating that their hair 
follicles had been prematurely induced into anagen (Fig lB). A 
macroscopic evaluation of the back skin from the mice receiving 
PTH (7-34) revealed a time-dependent increase in the skin area 
shovving progression from te logen into anagen (Fig 2A). By the 14 
day of treatment with PTH (7-34), there was a 1.31 % increase in the 
area on the back that was in an agen when compared to the control 
mice. A representative histologic cross-section of the middle region 
of the back skin from a control mouse at day 14 of treatment 
shovved the hair follicles were still in telogen (Fig 3A) whereas, in 
contrast, the hair fo llicles of mice that h ad received PTH (7-34) 
were in anagen (hair follicles producing melanin and hair shafts) 
(Fig 3B). M orphometric analysis of pa.rallel reference areas in th e 
middle back region revealed that after 14 days of treatment, the 
telogen anim als that received PTH (7-34) showed 99 ± 4.5% 
(mean ± SEM) of the h air follicles in anagen , whereas 100% of the 
hair follicles in the control group rem ained in telogen (Fig 4A). 
Prolongation of Anagen and Delay of Catagen by PTH 
(7-34) in Mice that Were in Spontaneous Anagen We next 
determin ed whether we could prolong anagen and delay catagen 
devel opment: in mice that were in spontan eous an agen with PTH 
(7-34). Mice that received PTH (7-34) showed a signi ficant 
prolongation of anagen as judged by the larger area of dark black 
skin over the back w hen compared to con tro ls (Fig lq. T he 
percent of back skin area in catagen and te logen progressed m ore 
rapidly in the contro l m ice th an in the PTH (7-34)-treated mice 
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(Fig 2B) . By day 9 of treatment, most of the back skin area of 
con tro l mice were in ca tagen or te logcn (67 ± 9.2%; mean ± 
SEM), w hercas PTH (7- 34) inhibited th e progression into catagen 
(only 27.9 ± 6.0%; mean ± SEM of the back aTea of test mice were 
in catagen). This was quan tified a.nd confirmed by morphometric 
analysis (Fig 4B), which showed that 19 ± 4% (mean ± SEM) of 
the hair follicles in the middle back region remained in anagen V I 
in mi ce treated w ith PTH (7-34) , whereas none (0%) were in 
an agen in the contro l group (Fig 4B) . Furthem10re, w hereas almost 
100% of the hair fo llicles of control mice progressed into late 
c,Hagen and telogen , only 17 ± 9'Vo (mean ± SEM) of the h air 
fo llicles had progressed into late catagen, and none of the follicles 
progressed to telogen in the PTH (7-34)- treated mice. 
Inhibition o f Catagen in Anagen-Induced Mice by PTH 
(7-34) In the third set of experiments, 6- to 8-wk-old adolescent 
CS7BL/6 mice with all fo llicles arrested in te logen for several 
weeks were selected. Anagen was induced in aU back skin follicles 
by hair shaft depilation with wax/rosin-mLxture (Paus et ai , 1990, 
1994a, 1994c). T his achieves the highest degree of cycling syn-
chrony obtainable by any technique. Seventeen to 19 d afte r an agen 
induction by depilation, these adolescen t mice enter catagen spon-
taneously (Paus et ai, 1990, 1994a, 1994c). We were interested in 
determining whether PTH (7-34) could re tard spontaneous cata-
gen development in these anagen-induced adolescent mice. T his 
allowed us to judge, precise ly, in a very large homogeneous 
population of ,111agen V ] follicles, the effects of PTH (7- 34) on 
valious ca tagen-associated regression phases of m ature hair folli-
cles, which are characterized by coordinated keratinocyte d ifferen-
tiation and apoptosis (Straile et ai, 1961; Paus e/ ai, 1990, 1994a, 
1994c). 
Figure ID shows representative anima ls just b efore sacrifice. 
T he control mice had grayish-pink skin, especially in the n eck area, 
w hich indicated the progression of the follicles in the hair cycl e 
fi'om catagen into telogen. In con trast, the mi ce that received PT H 
(7-34) had a substantially larger area of darker skin , consisten t with 
the hair folli cles remaining in anagen (Fig ID) . By the ninth d ay, 
PTH (7-34) markedly inhibited the progression of tbe h air follicl e 
from anagen to ca tagen , and this effect was sustained to th e 11th 
day (Fig 2q. Microscopic analysis of the hair fo llicles frOI11 mice 
trea ted wi th PT H (7-34) showed that 22.3 ± 1.4% (mean ± SEM) 
remained in anagen VI compared to only 1.3 ± 0.7% (mean ± 
SEM) of the control group (Figs 3C,D; 4q. T h e inhibition of 
ca tagen development by PTH (7-34) was furth er supported by the 
observation that the p ercentage of h air follicl es in the early stages of 
catagen development was significa.ntly higher in PTH (7- 34)-
trea tcd mice than in the contro ls, where middle and late stages of 
catagen development dominated (Fig 4q. 
Blood Calcium Determinations in the Control and PTH 
(7-34)-Treated Mice An evalu ation of the blood from the 
contro l and treated mice for all experim ents d id not reveal an y 
significan t diffe rences in the levels of calciul11 (8.7 ± 0.1 liS 8.6 ± 
0. 6; I' = 0.84 in control and PTH (7- 34)-treated mice, respective-
ly). 
DISC USSION 
Our findings provide con vincing evidence that PTH (7- 34), either 
by preventing endogenous PTHrP fi'om in teracting with its recep-
tor Ouppner e/ ai, 1991; Uren a et ai, 1993) , by interacting with 
another as yet unidentified PTHrP receptor, or by affecting a.nother 
ul11'elated receptor, accelerated anagen development in telogen 
fo llicl es. In addition , PTH (7- 34) m aintained active hair follicl e 
g rowth and hair shaft formation for a significan tly longer period 
than found naturally. With the exception of FGF- S (Hebert et ai, 
1994), this suggests that PTHrP is th e only otl1er endogenous factor 
identified to date to be critically involved in anagen termination or 
catagen induction, two currently indistinguishable and probably 
iden tical processes (Straile e/ ai, 1961; Paus et ai , 1991, 1994a, 
1994b , 1994c). 
930 SCI-I ILLI liT AI. 
T he anagen induction and catagen inhibition in rapidly cycling 
infantile mi ce by PTH (7-34) may reflect an acceleration of the 
unknown "biologic clock" that drives hai r cycling. PTH (7-34) 
could either be replacing the natural anagen initiation signal or 
counteracting PTHrP as a " brake" on anagen development. Alter-
natively, PTH (7- 34) may directly antagonize the natura l catagen 
initiation signal(s). T hat PTH (7-34) prolonged anagen and inhib-
ited catagen in adolescent anagen-induced mice fu rther supports 
the concept that PTHrP is a key signal for hair fo llic le regression 
because the follicles in these o lder mice were re latively slow 
cycling, w hich makes interference w ith the in trins ic generator of 
fo llicle cycling a less li kely explanation. 
During its dcvelopmcnt and its postnatal cycl ic remodeling, the 
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F igure 1. Representative mice u sed for macroscopic eval_ 
nation d emonstrating the eHect ofPTH (7-34) on the hair 
cycle. (A) 24 -d-old C57BL/6 mice from C harl es River Breeding 
Llboratories that were in tclogen before (I~ft) and after (lIIiddle) hait 
was shaved. The pinkish-w hi te nonpigmented skin is indicative of 
the te logen phase (lIIiddle). A mOllse that was in anagen and shaved 
showed marked dark grayish-b lack skin pigmentation characteris_ 
tic of anagen (right). (B) Acce leration of anagen deve lopment in 
spon tan eously cycl ing mice . 0 " the 1~/i is a representative control 
mouse demonstrating pinkish-white skin co lor consistent with the 
hair fo lli cles be ing in te logen as compared to the PTH (7- 34)_ 
treated m ouse (r(ght) , w hich showed marked increase in pigmen-
tation especially over the lower back area, indicating that the hair 
follicles had progressed into ,magen. (C) R etarded catagcn/teiogen 
development in spontaneollsly cycl ing mice. After 9 d of treatment 
with ve hicle, a represe ntative mOllse (I~) showed decreased 
pigmentation in the upper half of the back consistent with the 
animal's hair fo llicles having progressed into catagc n/tclogen . The 
mOll se on the right that received PTH (7-34) had marked black skin 
coloration ind icative that the hair follicles remained in "nagen. (D) 
Camgcn inhibition/3nagen prolongation in depilation-induced 
anagcll (nice. A representative control 1l10USC on the hifi showed 
decreased pib'll1entation over the upper back after 9 d of trcatment 
with control vehicle consistent with the animal's hair fo llicles 
ha ving progressed into catagen/te1ogen. T he mouse on the light 
that received PTH (7-34) showed maintenance of skin pigmenta-
tion indicative of hair foll icles be ing in anagen . 
hair follicle is essentially an epithe lial-mesenchym al interactive 
sys tem whose development depends on a tightly choreographed 
series of messages exchanged between the dermal and epidermal 
cells (Paus el ai, 1990, 1991, 1994a, 1994b, 1994c) . It has been 
hypothesized that the hair cycle is controlled by an inhibition/ 
disinhibition system whereby a loca lly generated mitotic inhibitor 
("ch alone") that gradually accumulates during anagen causes entry 
of the fo llicle into catagen when presen t in sufficient concentrations 
(Chase, 1954). This "chalone hypothesis " further stipula tes that the 
grad ual loss of activity or the dispersal of the inhibitor during 
te logen eventually disinhibits fo llicle growth, a process that may be 
accelerated by the depilation of telogen hair shafts . It is now 
recognized that w hile human cultured keratinocytes and keratino-
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Figure 2. Effect ofPTH (7-34) on the hair cycle stage represented by macroscopic evaluation of percent area of back skin. (A) T wo separate 
groups containing six to seven 24-d-o ld C5711L/ 6 mice were given either J f-Lg of PTH (7-34) in 0.1 ml distilled water (n = 14) or vehicle alone (n = l3) 
twice daily intraperitonea lly for 14 d. T he skin color was evaluated as a macroscopic indicator of what hair cycle stage the hair follicl es were in for the mice 
in each group on days 12, 13, and 14 of treatment. One control mouse died of unknown causes. (B) Two groups of seven 28-d-o ld anagen mice were g iven 
ei ther 1 f-Lg ofPTH (7- 34) (n = 14) or vehicle alone (n = 14) twice daily intraperitoneally for 9 d . The skin colo r of the mice from each group was evaluated 
a ll day 7, 8, and 9 of treatment. (C) Three groups of four to six 6- to 8-wk-old telogen mice were depilated to induce anagen . Starting o n day 9 post 
depilation , when aHmicc had reached anagen, they were given either 1 f-Lg PT H (7-34) (n = 15) or vehicl e alone (n = 15) twice daily in traperitol",a ll y for 
10 d. The skin color of the mice £i·om the treated and control groups were eva luated on day 9 and 10 and on the 11 th d:IY at the time of sacrifi ce. T hese 
panels C0 l11pare the 111C311S fronl pooled data derived froill two to three separate e xpcrinlCnts o f groups consisting of fouf to seven Jnice representing a tota l 
of 13 to 15 mice stud ied for each u·eatrnent da y. The data and the means ± SEM and levels of signifi cance were calculated using the Mann-Whitney U-test 
(*** , p < 0.001; " , I' < 0.01; " p < 0.05). Each experiment by itself showed similar statisti ca l signifi cance . 
cytes s urrounding the hair fo llicle produce PTHrP (Merendino el nl, 
1986; Hayman cl nl, 1989), they do not possess a PTH/PTHrP 
receptor (Hanafin el nl, 1995; Lee eI nl, 1995). It is not known 




the brain and pancreas, is present ill the hair follicle or whether it 
recognizes PTH (7-34) (Usdin Ci nl, 1995) . C ultured human skin 
fibroblasts and the dermal papilla, however, express mRNA for the 
PTH / PTHrP receptor (Hanafin et nl, 1995; Lee ct nl, 1995) . T hus, 
-O.5mm 
Figure 3. Effect ofPTH (7-34) on hair follicle histology. (A) Acceleration of anagen development in 24-d-old. spontaneously cycling mice. On day 
14 of treatment, the control mouse stiII showed mostly te~ogen follicles with condensed derma l papilla [dp 's] (~). The skin is ve ry thill. T hi s is compared 
to the skin of the PTH (7-34)-u·eated mouse (B) . T he skin IS not o llly much thI cker (appro:\;nHltely 2 times) but also contained the characteri sti cally large 
anagen hair bulbs with activated large dp' s (~), that extend to the suhcutis all producing melanin (~) and pigmented hair shafts (~). (C) atagen 
inhibition/anagen prolongation in adolescent, depilation-induced anagen mice . Hair follicles from a mouse receiving vehicle alone showed the hair fo llicles 
in telagen on the 1I th day of treatment (day 19 post depilation). Hair follicles from a mouse treated with PTH (7-34) showed the persistence of characteristi c 
allagen VI hair fo llicles. (D) All pictures were taken with the same magnification (X 100) and represent comparahle arcas in the midd le region of the hack 
(A-D , scale bar, 0.5 mm). 
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F ig ure 4. Histomorphometric analysis of the hair follicles from the back skin of control and PTH (7-34)-treated mice 011 the day of 
maximal macroscopic effects. (A) O n the 14th day of treatment of tdogen mice, both the control and treated groups had 13 and 14 mice, respective ly. 
(B) On the 9th day of treatment of spontaneous anagen mice, both tbe comrol and treated gro ups had 14 mice each . (C) On the '11 th da y of treatment of 
depilation-ind uced anagen mice, the control and treated groups containcd 15 micc each. 1". values less than '1%; "*, p < 0.001; "*. P < 0.01; *, P < 0.05. 
if the hair follicle keratinocyte continues to produce PTHrP during 
its proli ferative phase, it, in turn , co uld exert its antimitotic activity 
on th e dermal papilla, thereby te rminating further h air growth and 
initiating th e fo ll icle into catagen and te logen. T his effect would 
render PTHrP an ideal candidate for being one of the long elu sive 
cutaneous chalones (Chase, 1954; Paus el Ill, 1990, 1991, 1994b, 
1994c). 
T here is additiona l evidence that PTHrP can alter the hair cycle . 
Transgenic mice that overexpressed PTHrP displayed a profound 
disturbance in hair follicle development, particularly in abdomina l 
skin , w here a complete lack of hair follicle formation was observed 
(Wysolmerski et Il l , 1994) . It was also found that w hereas the 
PTHrP agonist PTHrP (1 - 34) inhibited epidermal proliferation and 
had no effect on the n umber or length of hairs ofSKH- l mice, PTH 
(7-34) had a profound eliect on enhancing epidermal proHferati,on 
and increasing the number and length of hai r shafts (Holick ct Il l, 
1994). Because the SKH-l hairless mou se is not a good model for 
hair research, however, it is difficult to compare those results with 
o ur observations in C57 BL/6 mice. Al though it may be possible 
that PTH (7-34) had a direct effect on melanogenesis, there is no 
evidence from ill lJilJo studies to suggest that PTHrP or PTH (7-34) 
alter melanogenesis (Holick e( Il l , 1994; Wysolmerski el nl, 1994) . 
On the background of these data, our observations strongly suggest 
that PTHrP is a powerful hair cycle modu lator involved in anagen 
termination and telogen maintenance that functions as a molecular 
brake on anagen. 
Our observations demonstrating the dramatic effect of PTH 
(7-34) on the h air cycl e offers a new opportuni ty to develop PTH 
analogs for treating disorders of hair growth. AJthough the PTH 
(7-34) may have a relatively short circulating half-li fe (Kukreja ef 
Ill, 1994), it appears that once it reaches the hair folljcle, its biologic 
half-Life is prolonged, resulting in a profound effect on the hair 
cycle. 
I,Ve 1II0llid like 10 Iha"k DaIJid Jllckso" for his excelletll nt11110rk. T his lIIork lIIas 
SIIpl'0I1ed ill pnt1 by Natiollal IIIslilllles of H eallh Grnllls DK 43690 allli CA 
71119 -01 (MFH); Elldac,.ille Trni//illg Grntll DK 07201 (EO); allli Dellisehe 
K,.e1JS1li!fe WI I941PIl 1 (RP). 
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